Georgia's congressional delegation is advocating for FDA reconsideration of the drug elamipretide for Hope Filchak.

Merck MRK announced that the FDA has accepted for review the new drug application (“NDA”) seeking approval for its investigational, once-daily, oral, two-drug, single-tablet regimen of ...